News from Zyme and the companies we work with.
Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
Cambridge, UK – 15 July 2025 – Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results [...]
OMED Health Launches New Gastrointestinal Treatments and Services Through Personalized Health Plans
OMED Health Plans build on proprietary OMED Health Breath Analyzer to include clinician-led care pathways, personalized treatments, and clinical consultations Expanded high-value end-to-end solution positions business for rapid growth in [...]
SPT Labtech and Semarion Collaborate to Advance Automated Cell-Based Assay Workflows
Integration of firefly® liquid handling platform and SemaCyte® microcarriers enables flexible, miniaturized, and automated cell assay workflows Cambridge, UK, 9th July 2025: SPT Labtech, a global leader in innovative laboratory [...]
Centauri Therapeutics appoints Dr. Debra Barker as Chief Medical Officer
Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic ABX-01 clinical candidate is an immunotherapeutic, based on proprietary Alphamer® platform and designed [...]
Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth
Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK, 08 July 2025 – Optibrium, a leading developer of software [...]
SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel
Peer-reviewed study in the International Wound Journal compares pain levels of enzymatic debridement against current methods Study results indicate that Aurase Wound Gel can achieve debridement without any additional pain [...]
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
HERCULES, Calif. — July 7, 2025 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of [...]
Optibrium Partners with TalTech on EU-Funded PhD Programme to Advance Sustainable Drug Discovery
The research will focus on developing faster and more accurate methods for predicting drug metabolism CAMBRIDGE, UK, 02 July 2025 – Optibrium, a leading developer of software and AI solutions [...]
Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling Foundational paper to drive development of improved virtual cell models for rejuvenation target discovery Cambridge, UK, 1 July 2025: [...]
4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK, 01 July 2025 – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing [...]
Zyme Communications celebrates 15 years of providing specialist support for the life science sector
Cambridge and Manchester, UK, 25 June 2025: Zyme Communications Ltd. (Zyme), the life science specialist PR and marketing agency, today celebrates its 15-year anniversary, and introduces refreshed branding to reflect [...]
Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer’s drug discovery
Enhanced Genomics’ 3D multi-omics platform harnessed to rapidly identify multiple novel therapeutic targets that were undetectable using conventional genomic approaches Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug [...]
